The cost-effectiveness analysis of single-tablet efavirenz-based regimen among HIV-1 infected adults in China
In the context of treating HIV-1 infected adults in China, the STR of TLE400 demonstrated cost-effectiveness when compared to both the MTR of TLE400 and the MTR of TLE600.
Authors
- Z. B. Li (ORCID: https://orcid.org/0000-0003-0208-9523)
- Yunfeng Kong (ORCID: https://orcid.org/0000-0002-0777-3116)
- Pengyang Fan (ORCID: https://orcid.org/0000-0003-4354-6524)
- Haijun Zhang (ORCID: https://orcid.org/0000-0002-9958-1102)
- Haotian Chen (ORCID: https://orcid.org/0000-0001-5493-2549)
- Sitong Luo
Institutions
- Johns Hopkins University (US)
- Peking University (CN)
- Vanke (China) (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fpubh.2025.1429461
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40